About shanghai pharmaceuticals - SHPMF
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.
SHPMF At a Glance
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceutical Building
Shanghai, Shanghai 200020
| Phone | 86-21-6373-0908 | Revenue | 38.14B | |
| Industry | Pharmaceuticals: Major | Net Income | 632.58M | |
| Sector | Health Technology | 2024 Sales Growth | 4.104% | |
| Fiscal Year-end | 12 / 2025 | Employees | 49,402 | |
| View SEC Filings |
SHPMF Valuation
| P/E Current | 9.587 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 9.512 |
| Price to Sales Ratio | 0.158 |
| Price to Book Ratio | 0.613 |
| Price to Cash Flow Ratio | 6.037 |
| Enterprise Value to EBITDA | 6.588 |
| Enterprise Value to Sales | 0.271 |
| Total Debt to Enterprise Value | 0.846 |
SHPMF Efficiency
| Revenue/Employee | 771,995.355 |
| Income Per Employee | 12,804.648 |
| Receivables Turnover | 3.253 |
| Total Asset Turnover | 1.265 |
SHPMF Liquidity
| Current Ratio | 1.363 |
| Quick Ratio | 1.054 |
| Cash Ratio | 0.352 |
SHPMF Profitability
| Gross Margin | 10.255 |
| Operating Margin | 3.175 |
| Pretax Margin | 2.732 |
| Net Margin | 1.659 |
| Return on Assets | 2.099 |
| Return on Equity | 6.494 |
| Return on Total Capital | 3.405 |
| Return on Invested Capital | 5.787 |
SHPMF Capital Structure
| Total Debt to Total Equity | 89.208 |
| Total Debt to Total Capital | 47.148 |
| Total Debt to Total Assets | 28.822 |
| Long-Term Debt to Equity | 13.71 |
| Long-Term Debt to Total Capital | 7.246 |